Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mach

Showing results (161-170 of 250) with videos related to

Pageof 25
Sort By:
International Journal of Cancer|August 9, 1995
RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor linesM E Tschickardt, Y Lu, M Jacim, et al.
The American Journal of Pathology|August 1, 1991
Hyperexpression of interferon-gamma-induced MHC class II genes associated with reorganization of the cytoskeletonR J Ulevitch, L Kline, R D Schreiber, et al.
The Journal of Experimental Medicine|September 1, 1989
Correlation of structure with T cell responses of the three members of the HLA-DRw52 allelic seriesJ Gorski, C Irle, E M Mickelson, et al.
Human Immunology|January 1, 1989
DNA typing of DRw6 subtypes: correlation with DRB1 and DRB3 allelic sequences by hybridization with oligonucleotide probesJ M Tiercy, J Gorski, H Bétuel, et al.
Ophthalmic Research|December 15, 2000
The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on posttraumatic proliferative vitreoretinopathyU Ozerdem, B Mach-Hofacre, K Keefe, et al.
Molecular and Cellular Biology|January 1, 1989
Inherited immunodeficiency with a defect in a major histocompatibility complex class II promoter-binding protein differs in the chromatin structure of the HLA-DRA geneP Gönczy, W Reith, E Barras, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1976
No detectable reiteration of genes coding for mouse MOPC 41 immunoglobulin light-chain mRNAM G Farace, M F Aellen, P A Briand, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1982
Isolation of cDNA clones encoding HLA-DR alpha chainsC T Wake, E O Long, M Strubin, et al.
The Biochemical Journal|June 1, 1987
Characterization of N-linked oligosaccharides of an HLA-DR molecule expressed in different cell linesD Néel, B Merlu, E Turpin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1987
A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alphaP Seckinger, K Williamson, J F Balavoine, et al.
Pageof 25

Showing results (161-170 of 250) with videos related to

Sort By:
Pageof 25
International Journal of Cancer|August 9, 1995
RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor linesM E Tschickardt, Y Lu, M Jacim, et al.
The American Journal of Pathology|August 1, 1991
Hyperexpression of interferon-gamma-induced MHC class II genes associated with reorganization of the cytoskeletonR J Ulevitch, L Kline, R D Schreiber, et al.
The Journal of Experimental Medicine|September 1, 1989
Correlation of structure with T cell responses of the three members of the HLA-DRw52 allelic seriesJ Gorski, C Irle, E M Mickelson, et al.
Human Immunology|January 1, 1989
DNA typing of DRw6 subtypes: correlation with DRB1 and DRB3 allelic sequences by hybridization with oligonucleotide probesJ M Tiercy, J Gorski, H Bétuel, et al.
Ophthalmic Research|December 15, 2000
The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on posttraumatic proliferative vitreoretinopathyU Ozerdem, B Mach-Hofacre, K Keefe, et al.
Molecular and Cellular Biology|January 1, 1989
Inherited immunodeficiency with a defect in a major histocompatibility complex class II promoter-binding protein differs in the chromatin structure of the HLA-DRA geneP Gönczy, W Reith, E Barras, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1976
No detectable reiteration of genes coding for mouse MOPC 41 immunoglobulin light-chain mRNAM G Farace, M F Aellen, P A Briand, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1982
Isolation of cDNA clones encoding HLA-DR alpha chainsC T Wake, E O Long, M Strubin, et al.
The Biochemical Journal|June 1, 1987
Characterization of N-linked oligosaccharides of an HLA-DR molecule expressed in different cell linesD Néel, B Merlu, E Turpin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1987
A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alphaP Seckinger, K Williamson, J F Balavoine, et al.
Pageof 25